The Travere Therapeutics, Inc. Data Breach: Reported Filing Facts

Travere Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare diseases, placing it within the healthcare and life sciences sector. Given the nature of its business, the company likely maintains sensitive patient records, clinical trial data, and health-related information, which are subject to stringent privacy protections. This data breach was officially reported to the New Hampshire Attorney General in 2025, triggering formal disclosure requirements. If you have received a data breach notification letter from the company, it indicates that your personal or protected health information may have been involved in this security incident. We recommend reviewing the letter carefully to understand the specific scope of the exposure and the identity protection services being offered to affected individuals.

State

New Hampshire

Reported

October 27, 2025